跳至主要内容
临床试验/NCT01890356
NCT01890356已完成不适用

A Study of Transcranial Electrical Stimulation (TES) as a Maintenance Treatment for Depression

The University of New South Wales1 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2013年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
25
试验地点
1
主要终点
Montgomery Asberg Depression Rating Scale for Depression (MADRS)

研究概览

简要总结

Transcranial electrical stimulation (TES) techniques offer a novel treatment approach for depression and have shown promising efficacy. However, there is no published data to date on their effectiveness as a maintenance treatment. This study will investigate ways of using TES as a maintenance treatment to prevent relapse in depression.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •All participants will be ≥ 18 years old.
  • •Participants must have experienced a significant clinical response, defined as ≥ 50% decrease from baseline scores on the Montgomery Asberg Depression Rating Scale (MADRS).

排除标准

  • •Inadequate response to acute trial of TES.
  • •Suicidality.
  • •Clinically defined neurological disorder or insult.
  • •Metal in the cranium, skull defects, or skin lesions on scalp (cuts, abrasions, rash) at proposed electrode sites.
  • •Pregnancy (women of childbearing age will be asked to undergo a urine pregnancy test prior to starting the study).
  • •Concurrent long acting benzodiazepines, ritalin or dexamphetamine medication.
  • •Treatment for depression is changed during months 3-9 of the trial.

研究组 & 干预措施

Transcranial electrical stimulation

Experimental

干预措施: Transcranial electrical stimulation (Device)

结局指标

主要结局

Montgomery Asberg Depression Rating Scale for Depression (MADRS)

时间窗: 9 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Colleen Loo

Professor

The University of New South Wales

研究点 (1)

Loading locations...

相似试验